diallyl trisulfide has been researched along with thromboxane a2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, XY; Fang, LG; Li, YL; Liao, JZ; Liu, XF; Sun, YL; Yao, SZ; Yue, ZS | 1 |
Inoue, K; Liao, F; Ozaki, Y; Qi, R; Sato, K; Yatomi, Y | 1 |
2 other study(ies) available for diallyl trisulfide and thromboxane a2
Article | Year |
---|---|
Effect of allitridi on platelet aggregation, a preliminary study.
Topics: Allyl Compounds; Animals; Cyclooxygenase Inhibitors; Disulfides; Epoprostenol; Garlic; Humans; In Vitro Techniques; Plants, Medicinal; Platelet Aggregation; Rats; Sulfides; Thromboxane A2 | 1984 |
Inhibition by diallyl trisulfide, a garlic component, of intracellular Ca(2+) mobilization without affecting inositol-1,4, 5-trisphosphate (IP(3)) formation in activated platelets.
Topics: Allyl Compounds; Biological Transport; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Garlic; Humans; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Isoenzymes; Peptide Fragments; Phospholipase C gamma; Phosphorylation; Plants, Medicinal; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfides; Thrombin; Thromboxane A2; Type C Phospholipases; Tyrosine | 2000 |